Is External Ventricular Drain Infection Predictable in Neurosurgery Patients? A Following-up Study in Iran

AUTHORS

Arezoo Chouhdari 1 , Ilad Alavi Darazam ORCID 2 , Marzieh Shahrabi Farahani 3 , Majid Mokhtari ORCID 4 , Reza Goharani ORCID 3 , Mahdi Amirdosara 5 , Mohammadreza Hajiesmaeili ORCID 5 , *

1 Skull Base Research Center, Loghman Hakim Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Anesthesia and Critical Care Department, Anesthesiology Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4 Department of Pulmonary and Critical Care Medicine, Loghman Hakim Teaching and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

5 Anesthesiology Research Center, Loghman Hakim Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

How to Cite: Chouhdari A , Alavi Darazam I, Shahrabi Farahani M, Mokhtari M, Goharani R, et al. Is External Ventricular Drain Infection Predictable in Neurosurgery Patients? A Following-up Study in Iran, Arch Neurosci. 2021 ; 8(1):e103075. doi: 10.5812/ans.103075.

ARTICLE INFORMATION

Archives of Neuroscience: 8 (1); e103075
Published Online: February 9, 2021
Article Type: Research Article
Received: May 5, 2020
Revised: December 15, 2020
Accepted: December 29, 2020
Crossmark
Crossmark
CHECKING
READ FULL TEXT

Abstract

Background: External ventricular drains (EVDs) infection is a life-threatening complication.

Objectives: To investigate the rate of EVDs infection and its predictive factors in neurosurgery patients hospitalized at a tertiary teaching hospital in Iran.

Methods: In this survey, all patients referred to a subspecialty hospital in Tehran (Iran) with an external ventricular drain (EVDs) from Jun 23, 2018, to Jun 23, 2019, are monitored within 30 days of EVDs placement for infection. Data on demographic information, underlying diseases, number of EVD replacements, length of hospital stay, type consumed antibiotic before neurosurgery, length of tunneling, type of airway, duration of mechanical ventilation, duration of surgery(hours), surgeon name, APACHE II score, length of intensive care unit stay are collected. The diagnosis was based on the Center for Diseases Control and Prevention criteria for meningitis/ventriculitis and clinical vision of infectious or critical care specialists. A logistic regression model was developed to identify factors that can predict the infection.

Results: Of 81 patients with EVDs, 39 (48.1%) were infected. The mean age of patients was 44.33 ± 19.5 years, and 55.6% of them were male. According to the multiple logistic regression analysis, mechanical ventilation for more than 6 days (OR: 2.5, 95% CI: 1.6 - 3.56, P = 0.04) and length of tunneling > 5 cm (OR: 1.98, 95%CI: 1.87 - 4.76, P = 0.02) were identified as factors that could predict EVD infection. Also, consuming ceftazidime + vancomycin, as a prophylaxis agent, had a lower odds ratio for EVD infection (OR:0.4, 95% CI: 0.08 - 0.84, P = 0.04).

Conclusions: Regarding the predictive factors of EVDs infection, either in the present study or other studies, there should be strategies to manage this life-threatening infection in neurosurgery patients.

1. Background

Although several preventive strategies are available to prevent infection in patients who use external ventricular drains (EVDs), still 27% of these patients are at increased risk of infection (1-3). These patients are usually hospitalized at the Intensive Care Unit (ICU) in order to manage high intracranial pressure that may occur in several conditions such as intracranial hemorrhage, tumor, and hydrocephalus (4). Many risk factors are associated with EVDs infection, including different diagnosis, co-infection(s), neurosurgical operation, length of tunneling > 5 cm, catheterization for more than 11 days, intracranial pressure monitoring for more than 5 days, catheter type, repeated insertion of the catheter, and multiple catheter replacement (5, 6).

Several studies have investigated EVD-related infections, which reported an incidence rate of nearly 20% and various risk factors. EVD Infections not only increase the length of ICU and/or hospital stay, but also are associated with increased risk of morbidity and mortality of patients. Hence, identifying factors that increase the risk of such infections is necessary.

2. Objectives

This survey aimed to investigate predictive factors for EVDs infection in patients admitted to the neurosurgery ICU of the Loghman Hakim Hospital during 2018 - 2019.

3. Methods

In this longitudinal following-up study, 91 patients admitted to the neurosurgery ICU of Loghman Hakim Hospital in the city of Tehran (Iran) for EVDs replacement are investigated. All patients were followed-up for 30 days for EVDs infection. Ten patients were excluded due to one of the following reasons: presenting with an open skull fracture and cerebrospinal fluid (CSF) leakage, personal hospital discharge, referring to other centers, or death due to other reasons. Also, patients who developed an infection in less than two days after EVDs replacement were excluded. All patients were on intravenous antibiotic prophylaxis before and after neurosurgery. Moreover, none of the catheters were impregnated with antibiotics. All EVDs were placed by a resident of neurosurgery with at least 2 years’ experience. Data on demographic information (i.e., age and sex), underlying disease, diagnosis, number of EVD replacements, length of hospital stay, type of consumed antibiotic before neurosurgery, length of tunneling, type of airway, duration of mechanical ventilation, duration of surgery(hours), surgeon name, APACHE II score, length of ICU and hospital stay, and symptoms of the infection were collected. Laboratory tests (i.e. serum and CSF analysis) were also recorded. According to the Center for Diseases Control and Prevention, the criteria for ventriculitis or meningitis diagnosis are as follow: (1) positive CSF culture results plus clinical symptoms or CNS pleocytosis/cell count increase; or (2) in the case of negative CSF culture, clinical symptoms and increased pleocytosis of the central nervous system (CNS), increased serial measurement/cell count, hypoglycemia (less than 50% of simultaneous blood sugar), and increased lactate (more than 2 mmol/dL or 36 mg/lit) or gram-positive smear. In cases of suspected colonization, the simultaneous lumbar puncture was used. If there was intraventricular hemorrhage (IVH) or subarachnoid hemorrhage (SAH), correction of pleocytosis, based on concurrent blood counts, was administered (7-9). All diagnoses were confirmed by several infectious specialists. This study was approved by the ethical committee of Shahid Beheshti University of Medical Sciences, Tehran (ethic code: R.SBMU.RETECH.REC.1397.343).

3.1. Statistical Analysis

Descriptive results are reported using the mean, standard deviation (SD), and number and percentage. Bivariate analysis was performed to define the risk factors associated with infection, represented by relative risks and 95% confidence intervals. The chi-square and two-tailed Fisher’s exact tests were used for categorical variables. The independent t-test was used for continuous variables. A logistic regression model was developed to identify suspected risk factors of EVD infection. The model included variables that were significant at P < 0.1 in the bivariate analysis. Finally, the hazard function curve was plotted. Data were analyzed using SPSS version 19. Statistical significance was considered when P-value < 0.05.

4. Results

Of 81 eligible patients with EVDs, 39(48.1%) were infected (25 (55.6%) for males and 14 (38.9%) for female). According to the results of the bivariate chi-square analysis, there was no significant difference between participants concerning EVD infection rate, sex, age, diagnosis, medical history, APACHE II score, number of EVDs, time of EVDs, duration of surgery, type of airway, mechanical ventilation, time of antibiotic prophylaxis, CSF and serum factors analysis, and duration of ICU and hospital stay (P > 0.05) (Table 1). For those affected by EVDs and for others, the mean ± SD of the CSF lactate was 57.92 ± 28.49 and 55.81 ± 23.83 mg/lit, respectively. Mechanical ventilation for more than 6 days (OR: 2.3, 95% CI: 1.4 - 3.56, P = 0.04) and length of tunneling > 5 cm (OR: 2.5, 95% CI: 1.87 - 4.76, P = 0.01) could predict EVDs infection. In addition, those consuming ceftazidime + vancomycin were 70% less likely to develop EVD infection (OR: 0.3, 95% CI: 0.08 - 3.78, P = 0.04). The comparison between the two groups concerning the aforementioned factors is provided in Table 1. Besides, the final model of multiple logistic regression could predict the EVDs infection in patients admitted to the ICU (Table 2). There was no difference concerning the time since EVDs, so the length of ICU stay and EVDs infection but hazard function plot showed with increasing days of having external ventricular drain as well as with increasing the length of ICU stays, the incidence rate of EVDs infection increased. (Figures 1 and 2).

Table 1. Assessment of EVDs Infection in Patients with External Ventricular Drainsa
VariablesEVDs InfectionP-ValueOR (95% CI)
YesNo
Sex39 (48.1)42 (51.9)0.12 (0.76 - 5.76)
Male25 (55.6)20 (44.4)
Female (reference)14 (38.9)22 (61.1)
Age44.33 ± 19.544.88 ± 20.570.91.7 (0.9 - 4.2)
Diagnosis0.30.7 (0.3 - 1.85)
Vascular23 (46.9)26 (53.1)0.4 (0.2 - 3.23)
Brain tumor11 (47.8)12 (52.2)0.5 (0.4 - 1.45)
Shunt and malformation (reference)5 (55.6)4 (44.4)
Past medical history0.8
Diabetes (DM)2.9 (0.7 - 7.37)
Yes6 (50)6 (50)
No (reference)33 (47.8)36 (52.2)
Hypertension (HTN)0.30.6 (0.1 - 2.4)
Yes7 (389)11 (61.1)
No (reference)32 (50.8)31 (49.2)
Hyperlipidemia (HLP)0.10.7 (0.1 - 3.4)
Yes0 (0)2 (100)
No (reference)39 (49.4)40 (50.6)
Ischemic heart disease (IHD)0.10.3 (0.02 - 3.08)
Yes1 (20)4 (80)
No (reference)38 (50)38 (50)
Cerebrovascular attack (CVA)0.40.5 (0.07 - 3.71)
Yes2 (28.6)5 (71.4)
No (reference)37 (50)37 (50)
APACHE II score0.40.9 (0.1 - 1.5)
0 - 1513 (40.6)19 (59.4)0.8 (0.41 - 1.73)
16 - 1912 (57.1)9 (42.9)
20 - 30 (reference)14 (50)14 (50)0.6 (0.3 - 2.43)
Number of EVD0.3
One time35 (89.7)38 (90.5)0.8 (0.3 - 4.2)
More than one time (reference)4 (10.3)4 (9.5)
Time of EVDs, d7.34 ± 4.684.95 ± 3.860.091.2 (0.4 - 3.6)
> 615 (62.5)9 (37.5)
≤ 6 (reference)23 (41.1)33 (58.9)
Type of airway0.4
Intubation34 (50)34 (50)1.3 (0.6 - 2.5)
Awaked and spontaneous (reference)5 (138.5)8 (61.5)
Duration of surgery, h4.22 ± 1.204.12 ± 2.10.21.3 (0.7 - 1.86)
CSF lactate ≥ 360.91.5 (0.9 - 3.2)
Yes21 (48.8)22 (51.2)
No18 (47.4)20 (52.6)
Mechanical ventilation (MV)0.31.6 (0.9 - 2.5)
Yes34 (50.7)33 (49.3)
No (reference)5 (35.7)9 (64.3)
Length of time MV, d12.87 ± 12.188.57 ± 10.400.04b2.3 (1.4 - 3.56)
> 623 (60.5)15 (39.5)
≤ 6 (reference)16 (37.2)27 (62.8)
Use of antibiotic prophylaxis0.04b
Ceftazidim + vancomycin17 (39.5)26 (60.5)0.3 (0.08 - 0.78)
Vancomycin + meropenem ( ± other antibiotics) (reference)22 (57.9)16 (42.1)
Length of tunneling, cm0.01b2.5 (1.87 - 4.76)
> 59 (69.2)4 (30.8)
≤ 5 (reference)36 (44.1)38 (55.9)
Length of time antibiotic prophylaxis, d15.69 ± 3.7113.68 ± 8.370.51.2 (0.76 - 8.23)
> 921 (55.3)17 (44.7)
≤ 9 (reference)18 (41.9)25 (58.1)
Length of time ICU stay, d13.87 ± 3.6710.55 ± 2.270.11.04 (0.6 - 1.98)
> 1022 (56.4)17 (43.6)
≤ 10 (reference)17 (40.5)25 (59.5)
Length of time hospital stay, d22.33 ± 9.6121.1 ± 12.220.11.8 (0.8 - 3.21)
> 1423 (57.5)17 (42.5)
≤ 1416 (39)25 (61)

Abbreviations: CI, confidence interval; OR, odds ratio.

aValues are expressed as No. (%) or mean ± SD.

bIndicates statistical significance.

Table 2. Final Model of Multiple Logistic Regression to predict EVDs Infectiona
VariablesOR (95% CI)P-Value
Time of EVDs, d0.08
> 61.1 (0.4 - 3.6)
≤ 6 (reference)
Length of time MV, d0.04*
> 62.5 (1.6 - 3.56)
≤ 6 (reference)
Use of antibiotic prophylaxis0.04*
Ceftazidim + vancomycin0.4 (0.08 - 0.84)
Vancomycin + meropenem (± other antibiotics) (reference)
Length of tunneling0.02*
> 51.98 (1.87 - 4.76)
≤ 5 (reference)

aThe adjusted odds ratio in multiple logistic regression analysis to predict EVDs infection. Statistical significance is indicated with a star (*).

Figure 1. Hazard function plot for assessing EVDs incidence based on the time since catheter placement
Figure 2. Hazard function plot for assessing EVDs incidence based on the ICU stay

5. Discussion

Although in the present study only two (5.1%) of cultures were positive with gram-positive or gram-negative micro-organisms, the prevalence of EVDs infections was 48.1%, which is more than the rate reported by several studies that used criteria similar to the present study (7-9). There was no difference between the patients concerning the variable of gender. Although There was no difference between infection rate and the number of catheter placement in neurosurgery patients …, but having a catheter was associated with an increased risk of EVDs infection (Figure 1). A study performed by Camacho EF mentioned the length of catheterization as an important risk factor for EVDs infection (OR: 10.3, 95% CI: 4 - 26, P = 0.04) (10). The aforementioned study also reported that the median length of hospitalization was higher in the EVDs infection group (OR: 42, 95% CI: 10 - 111, P = 0.007) (8). In the present study, there was no difference between the duration of surgery and catheter infection; however, Lu et al. (11) reported that the operation time in the infected group was longer than the non-infection group (4.66 ± 2.00 vs. 3.57 ± 1.33; t = 6.159, P = 0.014). In the same study, the logistic regression analysis confirmed that a preoperative ventricular-peritonea shunt, operative duration, blood transfusion during surgery, multiple CSF sampling, and EVDs duration were correlated with postoperative EVD-related infection (P < 0.05) (11). According to the findings, the length of mechanical ventilation was significantly higher in the EVDs infection group. However, there are studies that reported other results. It can be argued that patients who received mechanical ventilation for a long time often do not have a good physical condition, so they are at increased risk of catheter infection. In the current survey, the length of tunneling (> 5 cm) was associated with a higher incidence of EVDs infection. A study performed at the University of Florida on 100 patients with catheter < 5 cm reported an infection rate of zero (12, 13). Kim et al. (14) found an association between ventriculostomy-related catheter tract hemorrhage (VCTH) and Ventriculostomy-related infection (VRI). Although we did not use antibiotic-coated EVDs in the ICU of Loghman Hakim Hospital, but the efficacy of antibiotic-coated EVD (AC-EVD) in reducing the occurrence of EVDs was evaluated and confirmed (15, 16). Lang et al. (17) demonstrated a significant decline in ventriculostomy-associated CSF infection rate following the implementation of antibiotic-impregnated EVD catheters (0.9% vs 6%, P = 0.00128). Verberk et al. (18) reported that antibiotic-impregnated EVDs were not associated with a significant decline in the risk of VRIs in routine care. Also, it did not affect bacterial etiology. In this study, ceftazidim + vancomycin prophylaxis was associated with a lower risk of infection than vanco + meropenem (± other antibiotics) (39.5% vs. 57.9%). In another survey performed by Camacho et al. (10), no generation of cephalosporins was superior to other generations. Tsioutis et al. (19) reported that Gram-negative bacteria (GNB) predominated (57.9%) in the EVDs infection, followed by Gram-positive (36.8%) and fungi (5.3%). The current study had limitations, including not considering culture results when diagnosing the infection, because of the high prevalence of false-negative reports. Hence, the authors recommend further studies with higher accurate laboratory facilities and selecting participants from various healthcare facilities. We hope this study, despite its limitation, can provide useful information for considering risk factors for EVD infection.

Acknowledgements

Footnotes

References

  • 1.

    Edwards NC, Engelhart L, Casamento EM, McGirt MJ. Cost-consequence analysis of antibiotic-impregnated shunts and external ventricular drains in hydrocephalus. J Neurosurg. 2015;122(1):139-47. doi: 10.3171/2014.9.JNS131277. [PubMed: 25380105].

  • 2.

    Tunkel AR, Drake JM. Cerebrospinal Fluid Shunt Infections. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2010. p. 1231-6. doi: 10.1016/b978-0-443-06839-3.00085-0.

  • 3.

    Zabramski JM, Whiting D, Darouiche RO, Horner TG, Olson J, Robertson C, et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg. 2003;98(4):725-30. doi: 10.3171/jns.2003.98.4.0725. [PubMed: 12691395].

  • 4.

    Sorinola A, Buki A, Sandor J, Czeiter E. Risk Factors of External Ventricular Drain Infection: Proposing a Model for Future Studies. Front Neurol. 2019;10:226. doi: 10.3389/fneur.2019.00226. [PubMed: 30930840]. [PubMed Central: PMC6428739].

  • 5.

    Chouhdari A, Ebrahimzadeh K, Rezaei O, Samadian M, Sharifi G, Hajiesmaeili M. Investigating related factors with mortality rate in patients with postoperative meningitis: One longitudinal follow up study in Iran. Iran J Neurol. 2018;17(2):82-5. [PubMed: 30210733]. [PubMed Central: PMC6131337].

  • 6.

    Chouhdari A, Hajiesmaeili M, Rezaee O, Samadian M, Sharifi G, Pakdaman H, et al. Mortality Prediction in Patients with Post-Operative Meningitis: One Longitudinal Study in Iran. Arch Neurosci. 2019;In Press(In Press). doi: 10.5812/ans.86650.

  • 7.

    Ramanan M, Lipman J, Shorr A, Shankar A. A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections. BMC Infect Dis. 2015;15:3. doi: 10.1186/s12879-014-0712-z. [PubMed: 25567583]. [PubMed Central: PMC4300210].

  • 8.

    Jamjoom AAB, Joannides AJ, Poon MT, Chari A, Zaben M, Abdulla MAH, et al. Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland. J Neurol Neurosurg Psychiatry. 2018;89(2):120-6. doi: 10.1136/jnnp-2017-316415. [PubMed: 29070645]. [PubMed Central: PMC5800336].

  • 9.

    Peter S, Roman B. External Ventricular Drainage Infections: A Single-Centre Experience on 100 Cases. J Neurol Neurophysiol. 2016;7(4). doi: 10.4172/2155-9562.1000392.

  • 10.

    Camacho EF, Boszczowski I, Basso M, Jeng BC, Freire MP, Guimaraes T, et al. Infection rate and risk factors associated with infections related to external ventricular drain. Infection. 2011;39(1):47-51. doi: 10.1007/s15010-010-0073-5. [PubMed: 21264679].

  • 11.

    Lu P, Liu W, Gong J, Sun T, Li C; Raynald, et al. Risk Factors of External Ventricular Drainage-Related Infections: A Retrospective Study of 147 Pediatric Post-tumor Resection Patients in a Single Center. Front Neurol. 2019;10:1243. doi: 10.3389/fneur.2019.01243. [PubMed: 31849815]. [PubMed Central: PMC6892983].

  • 12.

    Tahir MZ, Sobani ZA, Murtaza M, Enam SA. Long-tunneled versus short-tunneled external ventricular drainage: Prospective experience from a developing country. Asian J Neurosurg. 2016;11(2):114-7. doi: 10.4103/1793-5482.145052. [PubMed: 27057216]. [PubMed Central: PMC4802931].

  • 13.

    Flint AC, Toossi S, Chan SL, Rao VA, Sheridan W. A Simple Infection Control Protocol Durably Reduces External Ventricular Drain Infections to Near-Zero Levels. World Neurosurg. 2017;99:518-23. doi: 10.1016/j.wneu.2016.12.042. [PubMed: 28012890].

  • 14.

    Kim J, Lee J, Feng R, Chartrain A, Sobotka S, Griffiths S, et al. Ventricular Catheter Tract Hemorrhage as a Risk Factor for Ventriculostomy-Related Infection. Oper Neurosurg (Hagerstown). 2020;18(1):69-74. doi: 10.1093/ons/opz148. [PubMed: 31294451].

  • 15.

    Mikhaylov Y, Wilson TJ, Rajajee V, Thompson BG, Maher CO, Sullivan SE, et al. Efficacy of antibiotic-impregnated external ventricular drains in reducing ventriculostomy-associated infections. J Clin Neurosci. 2014;21(5):765-8. doi: 10.1016/j.jocn.2013.09.002. [PubMed: 24411330].

  • 16.

    Cui Z, Wang B, Zhong Z, Sun Y, Sun Q, Yang G, et al. Impact of antibiotic- and silver-impregnated external ventricular drains on the risk of infections: A systematic review and meta-analysis. Am J Infect Control. 2015;43(7):e23-32. doi: 10.1016/j.ajic.2015.03.015. [PubMed: 25934064].

  • 17.

    Lang SS, Zhang B, Yver H, Palma J, Kirschen MP, Topjian AA, et al. Reduction of ventriculostomy-associated CSF infection with antibiotic-impregnated catheters in pediatric patients: a single-institution study. Neurosurg Focus. 2019;47(2). E4. doi: 10.3171/2019.5.FOCUS19279. [PubMed: 31370025].

  • 18.

    Verberk JDM, Berkelbach van der Sprenkel JW, Arts MP, Dennesen PJ, Bonten MJ, van Mourik MSM. Preventing ventriculostomy-related infections with antibiotic-impregnated drains in hospitals: a two-centre Dutch study. J Hosp Infect. 2016;92(4):401-4. doi: 10.1016/j.jhin.2015.12.018. [PubMed: 26895616].

  • 19.

    Tsioutis C, Karageorgos SA, Stratakou S, Soundoulounaki S, Karabetsos DA, Kouyentakis G, et al. Clinical characteristics, microbiology and outcomes of external ventricular drainage-associated infections: The importance of active treatment. J Clin Neurosci. 2017;42:54-8. doi: 10.1016/j.jocn.2017.03.023. [PubMed: 28342707].

  • Copyright © 2021, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
    COMMENTS

    LEAVE A COMMENT HERE: